SEC Info℠  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Carlyle Group Management L.L.C., et al. – ‘4’ for 2/4/20 re: 1Life Healthcare Inc.

On:  Wednesday, 2/5/20, at 4:37pm ET   ·   For:  2/4/20   ·   Accession #:  899243-20-3280   ·   File #:  1-39203

Previous ‘4’:  ‘4’ on 1/13/20 for 1/9/20   ·   Next:  ‘4’ on 5/11/20 for 5/7/20   ·   Latest:  ‘4’ on 12/9/21 for 12/8/21

Find Words in Filings emoji
 		  in    Show  and   ↓Hints

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 2/05/20  Carlyle Group Management L.L.C.   4                      1:34K  1Life Healthcare Inc.             Donnelley Fin’l S… 06/FA
          Carlyle Group Inc.
          Carlyle Holdings II GP L.L.C.
          Carlyle Holdings II L.L.C.
          CG Subsidiary Holdings L.L.C.
          TC Group Cayman Investment Holdings, L.P.
          TC Group Cayman Investment Holdings Sub L.P.
          TC Group VII, L.L.C.
          TC Group VII, L.P.
          Carlyle Partners VII Holdings, L.P.

Statement of Changes in Beneficial Ownership of Securities by an Insider   —   Form 4   —   SEA’34
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 4           Form 4 Submission -- doc4.xml/3.6                   HTML      4K


        

This ‘4’ Document is an XML Data File that may be rendered in various formats:

  Form 4    –   Plain Text   –  SEC Website  –  EDGAR System  –    XML Data    –  <?xml?> File
 
 
SEC Info℠ rendering:  Form 4 Submission
 
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
  
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
1. Name and Address of Reporting Person*
Carlyle Group Management L.L.C.
(Last)(First)(Middle)
C/O THE CARLYLE GROUP, 1001
PENNSYLVANIA AVE., N.W., SUITE 220 SOUTH
(Street)
WASHINGTONDC20004-2505
(City)(State)(Zip)
2. Issuer Name and Ticker or Trading Symbol
1Life Healthcare Inc [ ONEM ] 		5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
DirectorX10% Owner
Officer (give title below) Other (specify below)
3. Date of Earliest Transaction (Month/Day/Year)
2/4/20
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
Form filed by One Reporting Person
XForm filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock 2/4/20C 28,157,681A (1)28,157,681ISee footnotes (2) (3)
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Series A Preferred Stock (1) 2/4/20C 610,000 (1) (1)Common Stock610,000$0.000ISee footnotes (2) (3)
Series B Preferred Stock (1) 2/4/20C 86,904 (1) (1)Common Stock86,904$0.000ISee footnotes (2) (3)
Series C Preferred Stock (1) 2/4/20C 54,148 (1) (1)Common Stock54,148$0.000ISee footnotes (2) (3)
Series D Preferred Stock (1) 2/4/20C 116,535 (1) (1)Common Stock116,535$0.000ISee footnotes (2) (3)
Series E Preferred Stock (1) 2/4/20C 3,716,920 (1) (1)Common Stock3,716,920$0.000ISee footnotes (2) (3)
Series F Preferred Stock (1) 2/4/20C 4,705,523 (1) (1)Common Stock4,705,523$0.000ISee footnotes (2) (3)
Series G Preferred Stock (1) 2/4/20C 768,069 (1) (1)Common Stock768,069$0.000ISee footnotes (2) (3)
Series H Preferred Stock (1) 2/4/20C 400,467 (1) (1)Common Stock400,467$0.000ISee footnotes (2) (3)
Series I Preferred Stock (1) 2/4/20C 17,699,115 (1) (1)Common Stock17,699,115$0.000ISee footnotes (2) (3)
1. Name and Address of Reporting Person*
Carlyle Group Management L.L.C.
(Last)(First)(Middle)
C/O THE CARLYLE GROUP, 1001
PENNSYLVANIA AVE., N.W., SUITE 220 SOUTH
(Street)
WASHINGTONDC20004-2505
(City)(State)(Zip)
1. Name and Address of Reporting Person*
Carlyle Group Inc.
(Last)(First)(Middle)
C/O THE CARLYLE GROUP, 1001
PENNSYLVANIA AVE., N.W., SUITE 220 SOUTH
(Street)
WASHINGTONDC20004-2505
(City)(State)(Zip)
1. Name and Address of Reporting Person*
Carlyle Holdings II GP L.L.C.
(Last)(First)(Middle)
C/O THE CARLYLE GROUP, 1001
PENNSYLVANIA AVE., N.W., SUITE 220 SOUTH
(Street)
WASHINGTONDC20004-2505
(City)(State)(Zip)
1. Name and Address of Reporting Person*
Carlyle Holdings II L.L.C.
(Last)(First)(Middle)
C/O THE CARLYLE GROUP, 1001
PENNSYLVANIA AVE., N.W., SUITE 220 SOUTH
(Street)
WASHINGTONDC20004-2505
(City)(State)(Zip)
1. Name and Address of Reporting Person*
CG Subsidiary Holdings L.L.C.
(Last)(First)(Middle)
C/O THE CARLYLE GROUP, 1001
PENNSYLVANIA AVE., N.W., SUITE 220 SOUTH
(Street)
WASHINGTONDC20004-2505
(City)(State)(Zip)
1. Name and Address of Reporting Person*
TC Group Cayman Investment Holdings, L.P.
(Last)(First)(Middle)
C/O THE CARLYLE GROUP, 1001
PENNSYLVANIA AVE., N.W., SUITE 220 SOUTH
(Street)
WASHINGTONDC20004-2505
(City)(State)(Zip)
1. Name and Address of Reporting Person*
TC Group Cayman Investment Holdings Sub L.P.
(Last)(First)(Middle)
C/O THE CARLYLE GROUP, 1001
PENNSYLVANIA AVE., N.W., SUITE 220 SOUTH
(Street)
WASHINGTONDC20004-2505
(City)(State)(Zip)
1. Name and Address of Reporting Person*
TC Group VII, L.L.C.
(Last)(First)(Middle)
C/O THE CARLYLE GROUP, 1001
PENNSYLVANIA AVE., N.W., SUITE 220 SOUTH
(Street)
WASHINGTONDC20004-2505
(City)(State)(Zip)
1. Name and Address of Reporting Person*
TC Group VII, L.P.
(Last)(First)(Middle)
C/O THE CARLYLE GROUP, 1001
PENNSYLVANIA AVE., N.W., SUITE 220 SOUTH
(Street)
WASHINGTONDC20004-2505
(City)(State)(Zip)
1. Name and Address of Reporting Person*
Carlyle Partners VII Holdings, L.P.
(Last)(First)(Middle)
C/O THE CARLYLE GROUP, 1001
PENNSYLVANIA AVE., N.W., SUITE 220 SOUTH
(Street)
WASHINGTONDC20004-2505
(City)(State)(Zip)
Explanation of Responses:
(1)  The Preferred Stock converted into Common Stock on a one-for-one basis upon the closing of the Issuer's initial public offering and had no expiration date.
(2)  Carlyle Partners VII Holdings, L.P. is the record holder of the securities reported herein. Carlyle Group Management L.L.C. holds an irrevocable proxy to vote a majority of the shares of The Carlyle Group Inc., a publicly traded company listed on Nasdaq. The Carlyle Group Inc. is the sole member of Carlyle Holdings II GP L.L.C., which is the managing member of Carlyle Holdings II L.L.C., which, with respect to the securities reported herein, is the managing member of CG Subsidiary Holdings L.L.C., which is the general partner of TC Group Cayman Investment Holdings, L.P., which is the general partner of TC Group Cayman Investment Holdings Sub L.P., which is the sole member of TC Group VII, L.L.C., which is the general partner of TC Group VII, L.P., which is the general partner of Carlyle Partners VII Holdings, L.P.
(3)  Cont'd from footnote 2. Voting and investment determinations with respect to the shares of common stock held by Carlyle Partners VII Holdings, L.P. are made by an investment committee of TC Group VII, L.P. Accordingly, each of the foregoing entities may be deemed to share beneficial ownership of the securities held of record by Carlyle Partners VII Holdings, L.P. Each of them disclaims beneficial ownership of such securities.
Remarks:
Carlyle Group Management L.L.C., By: /s/ Anne Frederick, Attorney-in-fact for Curtis L. Buser, Chief Financial Officer 2/5/20
The Carlyle Group Inc., By: /s/ Anne Frederick, Attorney-in-fact for Curtis L. Buser, Chief Financial Officer 2/5/20
Carlyle Holdings II GP L.L.C., By: The Carlyle Group Inc., its sole member, By: /s/ Anne Frederick, Attorney-in-fact for Curtis L. Buser, Chief Financial Officer 2/5/20
Carlyle Holdings II L.L.C., By: Carlyle Holdings II GP L.L.C., its managing member, By: The Carlyle Group Inc., its sole member, By /s/ Anne Frederick, Attorney-in-fact for Curtis L. Buser, Chief Financial Officer 2/5/20
CG Subsidiary Holdings L.L.C., By: Carlyle Holdings II L.L.C., its managing member, By: Carlyle Holdings II GP L.L.C., its managing member, By: The Carlyle Group Inc., its sole member, By: /s/ Anne Frederick, Attorney-in-fact for Curtis L. Buser, CFO 2/5/20
TC Group Cayman Investment Holdings, L.P., By: /s/ Anne Frederick, Attorney-in-fact for Curtis L. Buser, Chief Financial Officer 2/5/20
TC Group Cayman Investment Holdings Sub L.P., By: /s/ Anne Frederick, Attorney-in-fact for Curtis L. Buser, Chief Financial Officer 2/5/20
TC Group VII, L.L.C., By: /s/ Jeremy W. Anderson, Authorized Person 2/5/20
TC Group VII, L.P., By: /s/ Jeremy W. Anderson, Authorized Person 2/5/20
Carlyle Partners VII Holdings, L.P., By: /s/ Jeremy W. Anderson, Authorized Person 2/5/20
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
____________
Transaction Code:
    C    Conversion of derivative security.

↑Top
Filing Submission 0000899243-20-003280   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)
Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
About — Privacy — Redactions — Help — Wed., Apr. 17, 9:11:16.1pm ET